Eli Lilly and Company (LLY)

LLY (NYSE:Drugs)
$54.14
neg -0.60
-1.10%
Today's Range: 53.89 - 54.50 | LLY Avg Daily Volume: 5,074,500
Last Update: 05/24/13 - 4:00 PM EDT
Volume: 4,983,689
YTD Performance: 9.77%
Open: $54.50
Previous Close: $54.74
52 Week Range: $39.93 - $58.41
Oustanding Shares: 1,126,561,464
Market Cap: 61,667,974,539
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 5 7 7 8
Moderate Sell 1 1 1 1
Strong Sell 3 3 3 2
Mean Rec. 2.74 2.77 2.77 2.64
Latest Dividend: 0.49
Latest Dividend Yield: 3.58%
Dividend Ex-Date: 05/14/13
Price Earnings Ratio: 13.13
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
13.13 13.10 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.24% 31.54% 64.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.90 0.04 0.01
Net Income 0.00 0.00 0.00
EPS -6.20 -0.07 -0.02
Earnings for LLY:
EBITDA 6.48B
Revenue 22.60B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.00 $0.94 $3.91 $2.75
Number of Analysts 8 7 12 10
High Estimate $1.05 $0.98 $3.96 $2.90
Low Estimate $0.95 $0.87 $3.85 $2.62
Prior Year $0.83 $0.79 $3.39 $3.91
Growth Rate (Year over Year) 21.08% 19.35% 15.39% -29.67%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
AustinJamison1
AustinJamison1: Pricing A Highly Probable Takeover Of MannKind http://t.co/dWVEGOipEN $LLY $MRK $NVO $PFE $MNKD
20 minutes ago from Tweet Button
OracleSix
OracleSix: RT @GantosJ: RT @brucejapsen Obamacare Will Bring Drug Industry $35B In Profits http://t.co/cUPhNZIm6l #ACA #Obamacare $ABT $PFE $LLY $BMY $ABBV $JNJ
5 hours ago from Twitter for Android
sstrella
sstrella: RT @brucejapsen: Obamacare Will Bring Drug Industry $35 Billion In Profits - Forbes http://t.co/mT1Mm5IuIJ #ACA #Obamacare $ABT $PFE $LLY $BMY $ABBV $JNJ
14 hours ago from Falcon Pro
GantosJ
GantosJ: RT @brucejapsen Obamacare Will Bring Drug Industry $35B In Profits http://t.co/cUPhNZIm6l #ACA #Obamacare $ABT $PFE $LLY $BMY $ABBV $JNJ
15 hours ago from TweetDeck
brucejapsen
brucejapsen: Obamacare Will Bring Drug Industry $35 Billion In Profits - Forbes http://t.co/mT1Mm5IuIJ #ACA #Obamacare $ABT $PFE $LLY $BMY $ABBV $JNJ
15 hours ago from Tweet Button
SeekingAlpha
SeekingAlpha: Diabetes And Oncology Might Cushion Eli Lilly's Fall Off A Patent Cliff http://t.co/Hc62Vk1PBV $A $QGEN $LLY
1 day ago from Seeking Alpha
micenter
micenter: Eli Lilly $LLY Could Break Through $55.64 Resistance Level ( http://t.co/ycc6mjHAhc )
2 days ago from Marketintelligencecenter.com
SeekingAlpha
SeekingAlpha: Billionaire Jim Simons' Top Dividend Stock Holdings http://t.co/R3e7CmOTSo $AZN $INTC $LLY $LO $PM
2 days ago from Seeking Alpha
EventsCIAA
EventsCIAA: RT @FiercePharma: Merck, Lilly, Pfizer form top ranks of $1B doc-payments list from FT http://t.co/2QPP9gPS6Z #pharma $MRK $LLY $PFE
2 days ago from web
megalomaniac
megalomaniac: Fave headline of day: $BI and $LLY launched a diabetes game called "Complications Combat". Not what ppl meant by gamifying health, I think.
2 days ago from iOS

Time to Cash In on Actavis

By

John Dorfman

| May 13, 2013 | 9:00 AM EDT
Here are seven reasons why.
Update
LLY Investor Mtg.
May 06, 2013 | 7:02 AM EDT
LLY - Eli Lilly Annual Shareholder Meeting - 11AM

It's Pipeline That Matters Most

By

Jim Cramer

| May 01, 2013 | 12:49 PM EDT
Focusing on near-term drug stock earnings is the wrong move.

National Lemming Day

By

Jim Cramer

| Apr 24, 2013 | 1:16 PM EDT
It’s the only thing that explains today’s action.

The Biotech Revaluation Is On

By

Jim Cramer

| Apr 17, 2013 | 6:20 AM EDT
These four names in particular have made some stunning moves.

Loving the Rally?

By

Gary Dvorchak

| Mar 11, 2013 | 9:30 AM EDT
Here is how I am picking apart the sectors looking for strong relative performance candidates.
Update
Cowen Healthcare Conf.
Mar 05, 2013 | 7:05 AM EST
Cowen Health Care Conference (Day 2 of 3) - 03/04/13 - 03/06/13 Boston, MA

Market on Close Imbalances Real Money Pro($)

By

Doug Kass

| Feb 28, 2013 | 3:56 PM EST
My mavens on the floor of the exchange see $1 billion to sell on the close.

Market on Close Imbalances Real Money Pro($)

By

Doug Kass

| Feb 15, 2013 | 3:52 PM EST
How much to buy?

Do Your Timely Dividend Research

By

Gary Dvorchak

| Feb 04, 2013 | 3:44 PM EST
Yields are dwindling, and here are some interesting events occurring in the next couple of weeks.

Columnist Conversation / Market Updates

Easy Money (Part One)
By Doug Kass
| May 25, 2013
| 8:45 AM EDT
"It's the lure of easy money. It has a very strong appeal." -Glenn Frey, Smuggler's Blues Investors bor...
SPX cash daily chart
By Carolyn Boroden
| May 24, 2013
| 3:24 PM EDT
There is no technical damage on the daily chart of $SPX at this point. Actually this decline is only similar to prior d...
See all »

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.